Alpha memo: resveratrol exercise training cross-context evidence signal

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

Minor issues

• The 45% cardiovascular increase figure in Receipt 2 is reported with units truncated in the supplied excerpt; the memo already flags this appropriately but could note the excerpt is bundled as reference-only.

Reviewer note

The alpha memo is a clean, bounded cross-context evidence signal. It names one anchor (resveratrol plus high-intensity exercise training) and pairs exactly two receipts that share it. The mechanistic mouse intestine signal (Nrf2/FTH1/GPX4, 2023) and the blunted cardiovascular signal in aged men (2013) are accurately described from the supplied excerpts: 15 mg/kg/day for 28 days in mice, and 250 mg/day for 8 weeks in 27 aged men (65 ± 1 y) with the 45% exercise-induced improvement that resveratrol did not augment. The title, topic, and cited receipts align on anchor, drug, and intervention. The memo avoids causal or clinical claims, states honestly that multi-axis differences (species, tissue, dose, duration, endpoint, baseline) preclude a direct overturning, and offers a specific falsifier (a human trial in aged men tracking both intestinal and cardiovascular endpoints). Limitations are specific and material, and the gaps/falsifier are concrete and actionable. Source grounding is direct and accurate for both receipts. Recommendation: accept.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: consensus

Prompt: reviewer-v11-research-synthesis